William Coley: The Pioneer and the Father of Immunotherapy
Authors:
Open Access
- 10 September 2024
- journal article
- review article
- Published by Springer Nature in Cureus
- Vol. 16 (9) , e69113
Abstract
William Coley was an unacclaimed hero of early cancer treatment. His work is often overshadowed by more recent advancements in immunotherapy. Coley’s innovative work in the 1910s and 1930s laid the groundwork for what would become a major field in oncology. His experiments with bacterial vaccines by making use of the immune system to combat cancer preceded contemporary immunotherapy for several decades. This review provides a comprehensive exploration of Coley’s life, his groundbreaking research, the socio-scientific challenges he faced, and his lasting impact on cancer treatment. Even though he faced lots of initial resistance and challenges, Coley's work has influenced modern immunotherapy practices.Keywords
This publication has 12 references indexed in Scilit:
- The Evolution of Cancer ImmunotherapyVaccines, 2021
- The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implicationsCellular & Molecular Immunology, 2020
- Talkin’ Toxins: From Coley’s to Modern Cancer ImmunotherapyToxins, 2020
- Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational MedicineJournal of Innate Immunity, 2016
- Dr William Coley and tumour regression: a place in history or in the futurePostgraduate Medical Journal, 2003
- Coley's toxin: historical perspective.2002
- Coley Toxins — The First Century1990
- Clinical effect of Coley's toxin. II. A seven-year study.1962
- The Treatment of Inoperable Sarcoma by Bacterial Toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus).Proceedings of the Royal Society of Medicine, 1910
- CONTRIBUTION TO THE KNOWLEDGE OF SARCOMAAnnals of Surgery, 1891